First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
Janjigian, Yelena Y, Shitara, Kohei, Moehler, Markus, Garrido, Marcelo, Salman, Pamela, Shen, Lin, Wyrwicz, Lucjan, Yamaguchi, Kensei, Skoczylas, Tomasz, Campos Bragagnoli, Arinilda, Liu, Tianshu, Schenker, Michael, Yanez, Patricio, Tehfe, Mustapha, Kowalyszyn, Ruben, Karamouzis, Michalis V, Bruges, Ricardo, Zander, Thomas, Pazo-Cid, Roberto, Hitre, Erika, Feeney, Kynan, Cleary, James M, Poulart, Valerie, Cullen, Dana, Lei, Ming, Xiao, Hong, Kondo, Kaoru, Li, Mingshun, Ajani, Jaffer A
Published in The Lancet (British edition) (03.07.2021)
Published in The Lancet (British edition) (03.07.2021)
Get full text
Journal Article
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer
Shitara, Kohei, Ajani, Jaffer A., Moehler, Markus, Garrido, Marcelo, Gallardo, Carlos, Shen, Lin, Yamaguchi, Kensei, Wyrwicz, Lucjan, Skoczylas, Tomasz, Bragagnoli, Arinilda Campos, Liu, Tianshu, Tehfe, Mustapha, Elimova, Elena, Bruges, Ricardo, Zander, Thomas, de Azevedo, Sergio, Kowalyszyn, Ruben, Pazo-Cid, Roberto, Schenker, Michael, Cleary, James M., Yanez, Patricio, Feeney, Kynan, Karamouzis, Michalis V., Poulart, Valerie, Lei, Ming, Xiao, Hong, Kondo, Kaoru, Li, Mingshun, Janjigian, Yelena Y.
Published in Nature (London) (31.03.2022)
Published in Nature (London) (31.03.2022)
Get full text
Journal Article
Metformin plus lrinotecan in patients with refractory colorectal cancer: a phase 2 clinical trial
Bragagnoli, Arinilda Campos, Araujo, Raphael L. C., Ferraz, Mauricio Wagner, dos Santos, Lucas Vieira, Abdalla, Kathia Cristina, Comar, Fabiana, Santos, Florinda Almeida, Oliveira, Marco Antonio, Carvalheira, José Barreto Campello, Cárcano, Flávio Mavigner, da Silveira Nogueira Lima, João Paulo
Published in British journal of cancer (16.03.2021)
Published in British journal of cancer (16.03.2021)
Get full text
Journal Article
Metformin for the treatment of breast cancer: protocol for a scoping review of randomised clinical trials
Araujo, Carolina Fumico Massuda, Nunes, Lélia Cápua, Murta-Nascimento, Cristiane, Souza, Cristiano de Pádua, Bragagnoli, Arinilda Campos, Fukushima, Fernanda Bono, Vidal, Edison Iglesias de Oliveira
Published in BMJ open (09.08.2021)
Published in BMJ open (09.08.2021)
Get full text
Journal Article
Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649
Moehler, Markus, Xiao, Hong, Blum, Steven I, Elimova, Elena, Cella, David, Shitara, Kohei, Ajani, Jaffer A, Janjigian, Yelena Y, Garrido, Marcelo, Shen, Lin, Yamaguchi, Kensei, Liu, Tianshu, Schenker, Michael, Kowalyszyn, Ruben, Bragagnoli, Arinilda Campos, Bruges, Ricardo, Montesarchio, Vincenzo, Pazo-Cid, Roberto, Hunter, Shannon, Davenport, Eric, Wang, Jinyi, Kondo, Kaoru, Li, Mingshun, Wyrwicz, Lucjan
Published in Journal of clinical oncology (10.12.2023)
Published in Journal of clinical oncology (10.12.2023)
Get full text
Journal Article
Overall survival results for trifluridine/tipiracil plus bevacizumab vs capecitabine plus bevacizumab: Results from the phase 3 SOLSTICE study
Andre, Thierry, Falcone, Alfredo, Shparyk, Yaroslav V., Moiseenko, Fedor Vladimirovich, Polo, Eduardo, Csoszi, Tibor, Campos Bragagnoli, Arinilda Silva, Liposits, Gabor, Chmielowska, Ewa, Delaporte, Flore, Hassan, Hasnaa, Skanji, Donia, Amellal, Nadia, Saunders, Mark P.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Nivolumab (NIVO) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Expanded efficacy, safety, and subgroup analyses from CheckMate 649
Shitara, Kohei, Janjigian, Yelena Y., Moehler, Markus H., Garrido, Marcelo, Gallardo, Carlos, Shen, Lin, Yamaguchi, Kensei, Wyrwicz, Lucjan, Skoczylas, Tomasz, Campos Bragagnoli, Arinilda Silva, Liu, Tianshu, Tehfe, Mustapha, Elimova, Elena, Soleymani, Samira, Lei, Ming, Kondo, Kaoru, Li, Mingshun, Ajani, Jaffer A.
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article
Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 3-year follow-up from CheckMate 649
Janjigian, Yelena Y., Shitara, Kohei, Moehler, Markus H., Garrido, Marcelo, Gallardo, Carlos, Shen, Lin, Yamaguchi, Kensei, Wyrwicz, Lucjan, Skoczylas, Tomasz, Campos Bragagnoli, Arinilda Silva, Liu, Tianshu, Tehfe, Mustapha, Elimova, Elena, Bruges Maya, Ricardo Elias, Cleary, James M., Karamouzis, Michalis, Soleymani, Samira, Lei, Ming, Amaya-Chanaga, Carlos, Ajani, Jaffer A.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 3-year follow-up from CheckMate 649
Janjigian, Yelena Y., Shitara, Kohei, Moehler, Markus H., Garrido, Marcelo, Gallardo, Carlos, Shen, Lin, Yamaguchi, Kensei, Wyrwicz, Lucjan, Skoczylas, Tomasz, Campos Bragagnoli, Arinilda Silva, Liu, Tianshu, Tehfe, Mustapha, Elimova, Elena, Bruges Maya, Ricardo Elias, Cleary, James M., Karamouzis, Michalis, Soleymani, Samira, Lei, Ming, Amaya-Chanaga, Carlos, Ajani, Jaffer A.
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
Trifluridine-tipiracil plus bevacizumab versus capecitabine plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer ineligible for intensive therapy (SOLSTICE): a randomised, open-label phase 3 study
André, Thierry, Falcone, Alfredo, Shparyk, Yaroslav, Moiseenko, Fedor, Polo-Marques, Eduardo, Csöszi, Tibor, Campos-Bragagnoli, Arinilda, Liposits, Gabor, Chmielowska, Ewa, Aubel, Paul, Martín, Lourdes, Fougeray, Ronan, Amellal, Nadia, Saunders, Mark P
Published in The lancet. Gastroenterology & hepatology (01.02.2023)
Published in The lancet. Gastroenterology & hepatology (01.02.2023)
Get more information
Journal Article
Nivolumab plus chemotherapy versus chemotherapy as first-line treatment for advanced gastric cancer/gastroesophageal junction cancer/oesophageal adenocarcinoma (CheckMate 649): a multicentre, randomised, open-label, phase 3 trial
Janjigian, Yelena Y, Shitara, Kohei, Moehler, Markus, Garrido, Marcelo, Salman, Pamela, Shen, Lin, Wyrwicz, Lucjan, Yamaguchi, Kensei, Skoczylas, Tomasz, Bragagnoli, Arinilda Campos, Liu, Tianshu, Schenker, Michael, Yanez, Patricio, Tehfe, Mustapha, Kowalyszyn, Ruben, Karamouzis, Michalis V, Bruges, Ricardo, Zander, Thomas, Pazo-Cid, Roberto, Hitre, Erika, Feeney, Kynan, Cleary, James M, Poulart, Valerie, Cullen, Dana, Lei, Ming, Xiao, Hong, Kondo, Kaoru, Li, Mingshun, Ajani, Jaffer A
Published in The Lancet (British edition) (05.06.2021)
Published in The Lancet (British edition) (05.06.2021)
Get full text
Journal Article
First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) versus chemo in advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Expanded efficacy and safety data from CheckMate 649
Moehler, Markus H., Shitara, Kohei, Garrido, Marcelo, Salman, Pamela, Shen, Lin, Wyrwicz, Lucjan, Yamaguchi, Kensei, Skoczylas, Tomasz, Campos Bragagnoli, Arinilda Silva, Liu, Tianshu, Schenker, Michael, Yanez, Patricio Eduardo, Tehfe, Mustapha, Li, Mingshun, Cullen, Dana, Memaj, Arteid, Lei, Ming, Xiao, Hong, Janjigian, Yelena Y., Ajani, Jaffer A.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Results of the JAVELIN Gastric 100 phase 3 trial: avelumab maintenance following first-line (1L) chemotherapy (CTx) vs continuation of CTx for HER2− advanced gastric or gastroesophageal junction cancer (GC/GEJC)
Moehler, Markus H., Dvorkin, Mikhail, Ozguroglu, Mustafa, Ryu, Min-hee, Muntean, Alina Simona, Lonardi, Sara, Nechaeva, Marina, Campos Bragagnoli, Arinilda Silva, Coskun, Hasan Senol, Cubillo Gracián, Antonio, Takano, Toshimi, Wong, Rachel, Safran, Howard, Vaccaro, Gina M., Boku, Narikazu, Conti, Ilaria, Hong, Janet, Xiong, Huiling, Taieb, Julien, Bang, Yung-Jue
Published in Journal of clinical oncology (01.02.2020)
Published in Journal of clinical oncology (01.02.2020)
Get full text
Journal Article
Brazil-TNT: A Randomized Phase 2 Trial of Neoadjuvant Chemoradiation Followed by FOLFIRINOX Versus Chemoradiation for Stage II/III Rectal Cancer
Bugano, Diogo Diniz Gomes, Santos, Vanessa Montes, Campos-Bragagnoli, Arinilda, Melo, Julia Carole Medeiros, Romagnolo, Luis Gustavo Capochin, Barbosa Neto, Osmar, Carvalho, Icaro Thiago, Karassawa-Helito, Juliana, Ortega, Cinthia D, Tridente, Cassia Franco, Gerbasi, Lucas Soares, Tustumi, Francisco, Giovani Blasi, Poliana Bergamaschine, Novaes Figueiredo de Araujo, Marleny, Pandini, Rafael Vaz, Seid, Victor Edmond, Portilho, Ana Sarah, Buosso, Albert, Rolla, Fabiana, Schettino, Guilherme de Paula Pinto, Araujo, Sergio Eduardo Alonso
Published in Clinical colorectal cancer (01.09.2024)
Published in Clinical colorectal cancer (01.09.2024)
Get full text
Journal Article
A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus
Janjigian, Yelena Y, Shitara, Kohei, Moehler, Markus, Garrido, Marcelo, Salman, Pamela, Wyrwicz, Lucjan, Yamaguchi, Kensei, Skoczylas, Tomasz, Bragagnoli, Arinilda Campos, Liu, Tianshu, Schenker, Michael, Yanez, Patricio, Tehfe, Mustapha, Kowalyszyn, Ruben, Karamouzis, Michalis V, Bruges, Ricardo, Zander, Thomas, Pazo-Cid, Roberto, Hitre, Erika, Feeney, Kynan, Cleary, James M, Poulart, Valerie, Cullen, Dana, Lei, Ming, Xiao, Hong, Kondo, Kaoru, Li, Mingshun, Ajani, Jaffer A
Published in Future oncology (London, England) (01.04.2023)
Published in Future oncology (London, England) (01.04.2023)
Get full text
Journal Article
Imatinib-induced bone edema: case report and review of literature
dos Santos, Lucas Vieira, Lima, João Paulo, Abdalla, Kathia Cristina, Bragagnoli, Arinilda Campos, Santos, Florinda Almeida, dos Anjos Jácome, Alexandre, Porto, Fabiano Elias
Published in Journal of the National Comprehensive Cancer Network (01.10.2013)
Published in Journal of the National Comprehensive Cancer Network (01.10.2013)
Get more information
Journal Article